首页 › 基金 › Atreides Management, LP › NTRA

Atreides Management, LP 对 NTRA 的持仓历史

NATERA INC · 医疗保健

Atreides Management, LP 在 Q2 2026 的 13F 申报中披露持有 NTRA(NATERA INC)104,385 股,市值约 US$28.3M,约占其申报组合的 0.22%,在其申报持仓中市值排名第 38 位。 Atreides Management, LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)104.39K 股
申报持仓市值$28.34M
组合权重0.22%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Atreides Management, LP 对 NTRA 的持仓演变

Atreides Management, LP 于 Q2 2026 首次披露 NTRA 持仓:104,385 股(约 US$28.3M)。

逐季持仓明细

季度股数金额变化
Q2 2026 104.39K $28.34M 新进

关于 NTRA 与 13F 数据

NTRA(NATERA INC)属于医疗保健行业。我们追踪的基金中还有 52 只申报持有 NTRA,申报仓位最大的包括:摩根大通 (US$3.51B), Duquesne Family Office LLC (US$864.9M), Castle Hook Partners LP (US$704.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 NTRA 的基金

查看 NTRA 的全部基金持有人 →

常见问题

How long has Atreides Management, LP held NTRA?

Atreides Management, LP has disclosed NTRA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Atreides Management, LP's current position in NTRA?

As of Q2 2026, Atreides Management, LP holds 104.39K shares of NTRA (NATERA INC), valued at $28.34M, representing 0.22% of its reported portfolio and ranking #38.

Has Atreides Management, LP been buying or selling NTRA?

In the latest 13F filing (Q2 2026), Atreides Management, LP newly opened its position in NTRA.

Which other funds hold NTRA?

Other major institutional holders of NTRA include 摩根大通, Duquesne Family Office LLC, Castle Hook Partners LP, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.